Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

ClinicalTrials.gov ID: NCT01008033

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01008033. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of topical application of IDP-108 versus vehicle in treating patients with onychomycosis.

Study identification

NCT ID
NCT01008033
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Dow Pharmaceutical Sciences
Industry
Enrollment
870 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2009 (Type not available)
Primary completion
Nov 2011 (Actual)
Completion
Dec 2011 (Actual)
Last update posted
Jun 22, 2012

2009 – 2011

United States locations

U.S. sites
33
U.S. states
22
U.S. cities
32
Facility City State ZIP Site status
University of Alabama, Birmingham Birmingham Alabama 35233 —
HOPE Research Institute Phoenix Arizona 85050 —
Therapeutics Clinical Research San Diego California 92123 —
University Clinical Trials, Inc San Diego California 92123 —
University of California, San Francisco San Francisco California 94115 —
Longmont Medical Research Network Longmont Colorado 80501 —
The Savin Center, PC New Haven Connecticut 06511 —
Foot and Ankle Associates of Florida, Inc Altamonte Springs Florida 32701 —
International Dermatology Research, Inc. Miami Florida 33144 —
Ameriderm Research Ormond Beach Florida 32174 —
Augusta Centre for Dermatology and Skin Renewal, LLC Augusta Georgia 30909 —
Gwinnett Clinical Research Center, Inc. Snellville Georgia 30078 —
Northwest Clinical Trials Boise Idaho 83704 —
Hudson Dermatology Evansville Indiana 47714 —
Dermatology Specialists Louisville Kentucky 40202 —
Michigan Center for Research Corp. Clinton Township Michigan 48038 —
Academic Dermatology Albuquerque New Mexico 87106 —
Impact Clinical Trials New Hyde Park New York 11040 —
Radiant Research Cinncinati Ohio 45249 —
Haber Dermatology & Cosmetic Surgery South Euclid Ohio 44118 —
Oregon Dermatology and Research Center Portland Oregon 97219 —
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Temple University School of Podiatric Medicine Philadelphia Pennsylvania 19107 —
Palmetto Clinical Trial Services, LLC Greenville South Carolina 29607 —
Rivergate Dermatology Goodlettsville Tennessee 37072 —
Austin Dermatology Associates Austin Texas 78705 —
J & S Studies, Inc. College Station Texas 77845 —
Baylor Research Institute Dallas Texas 75246 —
Stephen Miller, MD, PA San Antonio Texas 78229 —
Dermatology Resarch Center Salt Lake City Utah 84124 —
The Education and Research Foundation, Inc. Lynchburg Virginia 24501 —
Virginia Clinical Research, Inc Norfolk Virginia 23507 —
Aurora Advanced Healthcare, Inc. - Clinical Research Center Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01008033, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2012 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.